Q4 2024 Management View CEO Mark Tarr emphasized strong financial performance in Q4 2024, with revenue increasing 12.7%, adjusted EBITDA rising 13.6%, and adjusted EPS growing 23.2%. Total discharge ...

At the outset of the COVID-19 pandemic, the federal government moved quickly to ensure hospitals and health systems were able to leverage telehealth services to respond efficiently and effectively to ...

Worried about skyrocketing prescription drug costs? Medicare's new spending cap is bringing welcome relief to seniors, with ...